These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. Lamm DL; Blumenstein BA; Crawford ED; Montie JE; Scardino P; Grossman HB; Stanisic TH; Smith JA; Sullivan J; Sarosdy MF N Engl J Med; 1991 Oct; 325(17):1205-9. PubMed ID: 1922207 [TBL] [Abstract][Full Text] [Related]
3. [Multiorgan failure following intravesical bacillus Calmette-Guerin administration: a case report]. Baba Y; Ishizu K; Jojima K; Joko K; Nakamura K; Takihara H; Naito K Hinyokika Kiyo; 1992 Sep; 38(9):1063-5. PubMed ID: 1414761 [TBL] [Abstract][Full Text] [Related]
4. Importance of urinary interleukin-18 in intravesical immunotherapy with bacillus calmette-guérin for superficial bladder tumors. Eto M; Koga H; Noma H; Yamaguchi A; Yoshikai Y; Naito S Urol Int; 2005; 75(2):114-8. PubMed ID: 16123563 [TBL] [Abstract][Full Text] [Related]
5. [A case of interstitial pneumonitis caused by intravesical bacillus Calmette-Guérin instillation]. Horinaga M; Nakamura K; Nishiyama T; Murai M Hinyokika Kiyo; 1999 Jul; 45(7):493-5. PubMed ID: 10466068 [TBL] [Abstract][Full Text] [Related]
6. Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical administration of Bacille Calmette-Guérin. Morgan MB; Iseman MD Am J Med; 1996 Mar; 100(3):372-3. PubMed ID: 8629686 [No Abstract] [Full Text] [Related]
7. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-1998. A 57-year-old man with fever and jaundice after intravesical instillation of bacille Calmette-Guérin for bladder cancer. N Engl J Med; 1998 Sep; 339(12):831-7. PubMed ID: 9750077 [No Abstract] [Full Text] [Related]
8. [Two cases of successful treatments with steroid for local and systemic hypersensitivity reaction following intravesical instillation of Bacillus Calmette-Guerin]. Shimasaki N; Yamasaki I; Kamada M; Syuin T Hinyokika Kiyo; 2001 Apr; 47(4):281-4. PubMed ID: 11411106 [TBL] [Abstract][Full Text] [Related]
9. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin. Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562 [TBL] [Abstract][Full Text] [Related]
10. [A case of interstitial pneumonia induced by intravesical administration of bacillus Calmette-Guerin (BCG)]. Naoki K; Yamaguchi K; Soejima K; Aoki T; Inoue T; Satou N; Shimada H; Fukunaga K; Kudo H; Kanazawa M Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Dec; 35(12):1383-8. PubMed ID: 9567086 [TBL] [Abstract][Full Text] [Related]
11. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer. Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020 [TBL] [Abstract][Full Text] [Related]
18. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients. Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729 [TBL] [Abstract][Full Text] [Related]